306 related articles for article (PubMed ID: 1642394)
1. The current management and prognosis of acral lentiginous melanoma.
Wells KE; Reintgen DS; Cruse CW
Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
[TBL] [Abstract][Full Text] [Related]
4. Acral lentiginous melanoma.
Ridgeway CA; Hieken TJ; Ronan SG; Kim DK; Das Gupta TK
Arch Surg; 1995 Jan; 130(1):88-92. PubMed ID: 7802583
[TBL] [Abstract][Full Text] [Related]
5. Unique prognostic factors in acral lentiginous melanoma.
Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
[TBL] [Abstract][Full Text] [Related]
6. Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?
Paolino G; Bekkenk MW; Didona D; Eibenschutz L; Richetta AG; Cantisani C; Viti G; Carbone A; Buccini P; De Simone P; Ferrari A; Scali E; Calvieri S; Silipo V; Cigna E; Viti GP; Bottoni U
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):842-8. PubMed ID: 27010139
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcomes of melanoma in acral location in Korean patients.
Roh MR; Kim J; Chung KY
Yonsei Med J; 2010 Jul; 51(4):562-8. PubMed ID: 20499423
[TBL] [Abstract][Full Text] [Related]
8. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
Kolla AM; Vitiello GA; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M; Beasley GM; Contreras CM; Lowe M; Zager JS; Osman I; Berman RS; Liebman TN; Stein JA; Lee AY
Cancer Control; 2021; 28():10732748211053567. PubMed ID: 34752172
[TBL] [Abstract][Full Text] [Related]
9. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
[TBL] [Abstract][Full Text] [Related]
10. Age as a prognostic factor in the malignant melanoma population.
Austin PF; Cruse CW; Lyman G; Schroer K; Glass F; Reintgen DS
Ann Surg Oncol; 1994 Nov; 1(6):487-94. PubMed ID: 7850555
[TBL] [Abstract][Full Text] [Related]
11. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
Reintgen DS; Cox C; Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of malignant melanoma in Taiwan.
Chen YJ; Wu CY; Chen JT; Shen JL; Chen CC; Wang HC
J Am Acad Dermatol; 1999 Dec; 41(6):945-9. PubMed ID: 10570378
[TBL] [Abstract][Full Text] [Related]
13. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
14. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
15. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
[TBL] [Abstract][Full Text] [Related]
16. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
17. Acral melanoma: a review of 185 patients with identification of prognostic variables.
Slingluff CL; Vollmer R; Seigler HF
J Surg Oncol; 1990 Oct; 45(2):91-8. PubMed ID: 2214797
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous melanoma. Prognostic classification of anatomic location.
Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
[TBL] [Abstract][Full Text] [Related]
19. Distinctive dermatoscopic features of acral lentiginous melanoma in situ from plantar melanocytic nevi and their histopathologic correlation.
Kawabata Y; Tamaki K
J Cutan Med Surg; 1998 Apr; 2(4):199-204. PubMed ID: 9558302
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous spectrum of acral melanoma: A clinicoprognostic study of 213 acral melanomas according to tumor site.
Moon HR; Kang HJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
J Am Acad Dermatol; 2018 Jan; 78(1):179-182.e3. PubMed ID: 29241776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
